Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact email@example.com.
ALDH2 Polymorphism, Alcohol Intake and the Attributable Burden of Cancer in East Asia: Systematic Review, Meta-Analysis, and Modelling Study
20 Pages Posted: 2 Sep 2022More...
Background: East Asian populations, where alcohol consumption is rising, has a high prevalence of the inactivated aldehyde dehydrogenase-2 (ALDH2) enzyme involved in alcohol metabolism. This study estimates the burden of alcohol-attributable cancer accounting for genotype-specific cancer risk and alcohol exposure.
Methods: We conducted a systematic review and meta-analysis of eight databases on cancer risk to derive alcohol dose-response curves by ALDH2 genotype. A simulation-based approach using the Global Burden of Disease modelling framework was applied to estimate the population attributable fraction (PAF), incidence, and disability-adjusted life- years (DALYs) lost to alcohol-attributable cancer.
Findings: We included 36 studies (68,411 participants) from China, Japan, and South Korea in the meta-analysis. Alcohol dose-response curves for liver, oesophageal, and oral cavity/pharynx cancer showed an increased risk for people with the inactivated ALDH2 genetic polymorphism, resulting in a higher burden of alcohol-attributable cancer compared to GBD estimates. Our methods estimated annual incidence of cancer of 256,915 cases, an underestimate of 80,692 cases compared to GBD estimates. Similarly, total DALYs lost annually was underestimated by 1.48 million.
Interpretation: The burden of liver, oesophageal, and oral cavity/pharynx cancer attributable to alcohol is underestimated in populations with the ALDH2 genetic polymorphism when compared to current estimates.
Funding: Health and Medical Research Fund, Food and Health Bureau, Government of the Hong Kong SAR (03170067).
Declaration of Interest: The authors declare that they have no competing interests.
Keywords: ALDH2, Alcohol, Burden of disease, cancer
Suggested Citation: Suggested Citation